GlassScriptPhysician profile
Anjul Sharma
NPI 1720299084
$4,144.40
in general payments reported to CMS, 2019-2025
16 companies · $647 in 2025
The $647 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,618 · 2021: $681 · 2022: $373 · 2023: $512 · 2024: $314 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,414 · Gift: $59.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,413.55 |
| Gift | $59.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,627.55 | 2019-2024 | Ozempic, Rybelsus |
| Medtronic, INC. | $938.84 | 2021-2025 | Minimed 780g |
| Dexcom, INC. | $510.22 | 2022-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Sequel Med Tech, LLC | $297.41 | 2025 | Twiist |
| Lilly USA, LLC | $178.75 | 2022-2023 | Mounjaro |
| Medtronic Minimed, INC. | $137.96 | 2019 | |
| Ascendis Pharma Endocrinology INC | $127.14 | 2023 | |
| Verity Pharmaceuticals INC. | $98.09 | 2025 | Tlando |
| Mannkind Corporation | $59.40 | 2023 | Afrezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.38 | 2022 | |
| Abbvie INC. | $42.86 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $20.17 | 2024 | Jynarque |
| Bayer Healthcare Pharmaceuticals INC. | $15.27 | 2024 | |
| Abbott Laboratories | $15.05 | 2024 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $14.67 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rhythm Pharmaceuticals, INC. | $14.64 | 2025 | Imcivree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anjul Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.